WuXi AppTec (OTCMKTS:WUXAY) is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.
The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.
Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets. The company was founded by Dr. Ge Li, who has served as its chairman and remains a prominent member of its leadership.
